Cite
HARVARD Citation
Saxena, A. et al. (2022). Breakthrough SARS-CoV-2 infections, morbidity, and seroreactivity following initial COVID-19 vaccination series and additional dose in patients with SLE in New York City. Lancet. pp. e582-e585. [Online].